Gilbert syndrome.

Area of Science:

• Genetics
• Hepatology
• Biochemistry

Background:

• Gilbert syndrome is an autosomal dominant hereditary condition characterized by intermittent unconjugated hyperbilirubinemia.
• It results from reduced uridine diphosphate-glucuronyl transferase (UGT1A1) activity, leading to indirect hyperbilirubinemia, often first noticed as mild jaundice in adolescence.
• While typically benign, it can potentiate severe hyperbilirubinemia or cholelithiasis when combined with other conditions like G-6-PD deficiency or thalassemia.

Discussion:

• Diagnosis is often one of exclusion, but molecular genetic testing for UGT1A1 polymorphisms, particularly the UGT1A1*28 variant, can confirm the genotype.
• The syndrome may affect drug metabolism and plasma oxidation, warranting consideration in clinical management.
• Understanding the genetic basis is crucial for differentiating it from more severe liver diseases.

Key Insights:

• Reduced UGT1A1 activity is the biochemical hallmark of Gilbert syndrome.
• The common UGT1A1*28 genotype is a key genetic marker.
• Clinicians should consider Gilbert genotype in unexplained indirect hyperbilirubinemia.

Outlook:

• Further research could explore the full impact of Gilbert syndrome on drug metabolism and long-term health.
• Genetic screening may become more routine for patients with persistent hyperbilirubinemia.
• Continued investigation into genotype-phenotype correlations will refine clinical understanding.